Compare WST & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | CHRW |
|---|---|---|
| Founded | 1923 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9B | 20.5B |
| IPO Year | 2004 | 1997 |
| Metric | WST | CHRW |
|---|---|---|
| Price | $337.66 | $150.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 20 |
| Target Price | ★ $325.86 | $181.05 |
| AVG Volume (30 Days) | 313.4K | ★ 1.1M |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | 0.30% | ★ 1.35% |
| EPS Growth | 1.49 | ★ 25.13 |
| EPS | ★ 4.07 | 2.78 |
| Revenue | $2,886,900,000.00 | ★ $14,869,380,000.00 |
| Revenue This Year | $6.76 | $5.07 |
| Revenue Next Year | $6.22 | $6.26 |
| P/E Ratio | $83.53 | ★ $53.11 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $223.83 | $123.64 |
| 52 Week High | $386.00 | $210.33 |
| Indicator | WST | CHRW |
|---|---|---|
| Relative Strength Index (RSI) | 42.04 | 46.08 |
| Support Level | $323.60 | $149.88 |
| Resistance Level | $359.48 | $153.25 |
| Average True Range (ATR) | 7.28 | 3.80 |
| MACD | -1.13 | 1.75 |
| Stochastic Oscillator | 18.37 | 75.27 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 64% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (26%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.